David Knoppert

901 total citations
29 papers, 573 citations indexed

About

David Knoppert is a scholar working on Pediatrics, Perinatology and Child Health, Epidemiology and Pharmacology. According to data from OpenAlex, David Knoppert has authored 29 papers receiving a total of 573 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pediatrics, Perinatology and Child Health, 9 papers in Epidemiology and 5 papers in Pharmacology. Recurrent topics in David Knoppert's work include Breastfeeding Practices and Influences (9 papers), Pharmaceutical studies and practices (7 papers) and Infant Development and Preterm Care (5 papers). David Knoppert is often cited by papers focused on Breastfeeding Practices and Influences (9 papers), Pharmaceutical studies and practices (7 papers) and Infant Development and Preterm Care (5 papers). David Knoppert collaborates with scholars based in Canada, United Kingdom and United States. David Knoppert's co-authors include David S.C. Lee, Anthony K.C. Chan, Janet I. Malowany, Marsha Campbell‐Yeo, Shinya Ito, Gideon Koren, Alex Kiss, Elizabeth Asztalos, M. Patricia Massicotte and John K. Wu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Antimicrobial Agents and Chemotherapy and Clinical Pharmacology & Therapeutics.

In The Last Decade

David Knoppert

27 papers receiving 537 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Knoppert Canada 13 202 198 138 103 99 29 573
Pamela D. Reiter United States 16 225 1.1× 86 0.4× 39 0.3× 61 0.6× 22 0.2× 45 617
Karen Berger United States 15 46 0.2× 104 0.5× 27 0.2× 38 0.4× 67 0.7× 54 566
Tsz-Yin So United States 12 75 0.4× 37 0.2× 26 0.2× 67 0.7× 25 0.3× 25 391
Shamsideen Abayomi Ogun Nigeria 10 64 0.3× 254 1.3× 18 0.1× 32 0.3× 29 0.3× 27 458
Shl Thomas United Kingdom 11 61 0.3× 110 0.6× 25 0.2× 116 1.1× 23 0.2× 27 617
Xiaozhang Jiang United States 12 339 1.7× 80 0.4× 14 0.1× 220 2.1× 6 0.1× 16 740
Jamie Falk Canada 13 66 0.3× 92 0.5× 8 0.1× 99 1.0× 14 0.1× 57 524
C. Jonkers Netherlands 13 65 0.3× 29 0.1× 11 0.1× 89 0.9× 14 0.1× 21 1.0k
R. Steven Tharratt United States 10 35 0.2× 39 0.2× 21 0.2× 70 0.7× 26 0.3× 16 507
Reem Masarwa Israel 14 108 0.5× 101 0.5× 5 0.0× 164 1.6× 16 0.2× 22 570

Countries citing papers authored by David Knoppert

Since Specialization
Citations

This map shows the geographic impact of David Knoppert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Knoppert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Knoppert more than expected).

Fields of papers citing papers by David Knoppert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Knoppert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Knoppert. The network helps show where David Knoppert may publish in the future.

Co-authorship network of co-authors of David Knoppert

This figure shows the co-authorship network connecting the top 25 collaborators of David Knoppert. A scholar is included among the top collaborators of David Knoppert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Knoppert. David Knoppert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Asztalos, Elizabeth, et al.. (2019). Role of days postdelivery on breast milk production: a secondary analysis from the EMPOWER trial. International Breastfeeding Journal. 14(1). 21–21. 4 indexed citations
2.
Asztalos, Elizabeth, et al.. (2018). Pregnancy gestation at delivery and breast milk production: a secondary analysis from the EMPOWER trial. SHILAP Revista de lepidopterología. 4(1). 21–21. 6 indexed citations
3.
Kelly, Lauren E., David Knoppert, Henry Roukema, Michael Rieder, & Gideon Koren. (2014). Oral Morphine Weaning for Neonatal Abstinence Syndrome at Home Compared with In-Hospital: An Observational Cohort Study. Pediatric Drugs. 17(2). 151–157. 26 indexed citations
4.
Asztalos, Elizabeth, et al.. (2012). Enhancing breast milk production with Domperidone in mothers of preterm neonates (EMPOWER trial). BMC Pregnancy and Childbirth. 12(1). 87–87. 19 indexed citations
5.
Knoppert, David. (2011). Safety and efficacy of drugs in pregnancy.. PubMed. 18(3). e506–12. 7 indexed citations
6.
MacLeod, Stuart & David Knoppert. (2009). Multidisciplinarity Goes Mainstream. Pediatric Drugs. 11(4). 227–228. 2 indexed citations
7.
Knoppert, David. (2009). Pediatric Formulations. Pediatric Drugs. 11(1). 55–56. 9 indexed citations
8.
Knoppert, David, et al.. (2008). The Infancy of an International Pediatric Pharmacy Network. Pediatric Drugs. 10(2). 71–73. 4 indexed citations
9.
Malowany, Janet I., Paul Monagle, David Knoppert, et al.. (2008). Enoxaparin for neonatal thrombosis: A call for a higher dose for neonates. Thrombosis Research. 122(6). 826–830. 80 indexed citations
10.
Malowany, Janet I., et al.. (2007). Enoxaparin Use in the Neonatal Intensive Care Unit: Experience Over 8 Years. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 27(9). 1263–1271. 74 indexed citations
11.
Knoppert, David, et al.. (2006). Paroxetine Toxicity in a Newborn After In Utero Exposure. Therapeutic Drug Monitoring. 28(1). 5–7. 20 indexed citations
12.
Knoppert, David, Diana Stempak, Sylvain Baruchel, & Gideon Koren. (2003). Celecoxib in Human Milk: A Case Report. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 23(1). 97–100. 18 indexed citations
13.
Zaw, Win, David Knoppert, & Orlando da Silva. (2001). Flumazenil's Reversal of Myoclonic‐like Movements Associated with Midazolam in Term Newborns. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 21(5). 642–646. 9 indexed citations
14.
Knoppert, David, et al.. (2001). Effect of domperidone on milk production in mothers of premature newborns: a randomized, double-blind, placebo-controlled trial.. PubMed. 164(1). 17–21. 96 indexed citations
15.
Knoppert, David. (2000). Guidelines for Administration of Intravenous Medications to Pediatric Patients. The Canadian Journal of Hospital Pharmacy. 53(4).
16.
Silva, Orlando da, et al.. (1999). Seizure and Electroencephalographic Changes in the Newborn Period Induced By Opiates and Corrected By Naloxone Infusion. Journal of Perinatology. 19(2). 120–123. 15 indexed citations
17.
Morley-Forster, Patricia, John D. McAllister, Hilde Vandenberghe, et al.. (1997). Does thiopentone delay recovery in children premedicated with midazolam?. Pediatric Anesthesia. 7(4). 279–285. 3 indexed citations
18.
Lee, David S.C., et al.. (1994). Myoclonus Associated with Lorazepam Therapy in Very-Low-Birth-Weight Infants. Neonatology. 66(6). 311–315. 19 indexed citations
19.
Knoppert, David, et al.. (1993). Stability of Ceftizoxime in 5 Percent Dextrose and 0.9 Percent Sodium Chloride. The Canadian Journal of Hospital Pharmacy. 46(1). 1 indexed citations
20.
Knoppert, David, Michael Spino, Raphael Beck, Jake J. Thiessen, & Stuart MacLeod. (1988). Cystic fibrosis: enhanced theophylline metabolism may be linked to the disease. Clinical Pharmacology & Therapeutics. 44(3). 254–264. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026